BridgeMD
New treatment option for Autism Spectrum Disorder
Official title Adaptation of the NEAR Cognitive Remediation Method to Child and Adult Autism by Including Social Scenarios and Skills
ClinicalTrials.gov ID: NCT05786898
What this study is testing
- What it's testing
- The investigators currently provide the NEAR method (neuropsychological educational approach to cognitive remediation) for people with neurocognitive difficulties, without distinguishing between ASD and schizophrenia. However, the NEAR method does not address social cognition in the stimulated functions.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 13 to 40
You may be able to join if
- Patients with a diagnosis Autism Spectrum Disorder (ASD) - (DSM5)
- Attending one of the outpatient units participating in the research
- Diagnosis confirmed by the ADI (Autism Diagnostic Interview) with at least one parent present; or by the ADOS (Autism Diagnosis Observation Schedule)
- Score of at least 7 on the WISC5 (children) or WAIS4 (adults) comprehension subtest
- Patient whose neuropsychological evaluation shows neurocognitive impairment as assessed by the neuropsychologist
You likely can't join if
- Previously known diagnosis of intellectual disability
- Misunderstanding of questions or instructions given during the diagnostic interview
- Proven neurological pathology
- Persons treated with electroconvulsive therapy within the last 6 months
- Uncorrected sensory perception disorder
- Patient participating in another research study with an exclusion period still in progress at inclusion
See the full eligibility criteria
- Patients with a diagnosis Autism Spectrum Disorder (ASD) - (DSM5)
- Attending one of the outpatient units participating in the research
- Diagnosis confirmed by the ADI (Autism Diagnostic Interview) with at least one parent present; or by the ADOS (Autism Diagnosis Observation Schedule)
- Score of at least 7 on the WISC5 (children) or WAIS4 (adults) comprehension subtest
- Patient whose neuropsychological evaluation shows neurocognitive impairment as assessed by the neuropsychologist
- Level of comprehension and communication allowing to understand the instructions of the exercises presented on the screen.
- For children, persons who can attend a non-specialized school
- If the patient is being treated with a psychotropic drug: stability of treatment for more than one month.
- Previously known diagnosis of intellectual disability
- Misunderstanding of questions or instructions given during the diagnostic interview
- Proven neurological pathology
- Persons treated with electroconvulsive therapy within the last 6 months
- Uncorrected sensory perception disorder
- Patient participating in another research study with an exclusion period still in progress at inclusion
- Treatment with daytime anxiolytics, and treatment with anticholinergic correctors
- Pregnant or breastfeeding woman
- Participants who have had cognitive remediation in the last two years Specific exclusion criteria for the "adult" group: \- heterogeneous levels of development highlighted in the diagnostic workup including an...
The study team makes the final eligibility decision.
Where it's taking place
- Paris, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 13 years to 40 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Paris, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.